HANGZHOU MINSHENG INSTITUTE FOR PHARMA RESEARCH CO., LTD.;HANGZHOU MINSHENG PHARMACEUTICAL CO., LTD.
发明人:
Weiliang XU,Jingya FANG,Feiyu FENG,Lan YANG,Dianwu GUO,Fujiang ZHU,Qiufu GE
申请号：
US15770138
公开号：
US20180311215A1
申请日:
2016.10.20
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention provides a pharmaceutical composition for injection comprising a NL-101 type compound and a preparation method thereof. The composition uses the NL-101 type compound as an active pharmaceutical ingredient, and the stability of the NL-101 type compound is improved by adding a chloride-containing stabilizing agent or using a co-solvent containing hydrochloric acid, so that the formulation can be stably produced and meet the requirements for clinical safe use.
